Clinical Trials
World-Class Research
The evidence-based science of brain photobiomodulation (PBM) is well-documented in over 20+ years of academic research and 600+ peer-reviewed papers. We partner with top research institutions to develop 1st-in-class wearable digital therapeutics.
Brain Pacer Efficacy Study (Healthy Subjects)
City University of New York (CUNY)
Depression (MDD)
Phase 2 Study
Harvard University/Massachusetts General Hospital (MGH), China Medical University (CMU/Taiwan)
Depression (MDD) in Child and Adolescent
Phase 2 Study
Harvard University/MGH
Attention-Deficit/Hyperactivity Disorder (ADHD)
Phase 1 Study
Stanford University, Hospital de Clinicas de Porto Alegre (Brazil), Institute of Neuroscience (INS, Italy)
ADHD with Autistic Traits in Child and Adolescent
Harvard University/MGH
ASD (Autism) in Adult/Child and Adolescent
Harvard University/MGH
In the News:
“At Mass. General, Paolo Cassano… is working on one of several pilot studies nationwide of transcranial infrared light therapy [which is] believed to decrease inflammation and oxidative stress in the brain as well as increase the formation of neurons.”
“Cassano thinks light therapy could provide a groundbreaking new tool for depression treatment — one that is affordable, without side effects and more immediate than medication.”
“New research at Massachusetts General Hospital is showing that it may be able to treat severe depression with the use of specialized light and without medication.”
“Exposure to a light that isn’t visible to the naked eye may be the next breakthrough treatment for depression. Massachusetts General Hospital psychiatrist Paolo Cassano, MD, PhD, and other researchers at MGH and elsewhere, are seeing encouraging results in studies of near-infrared light—the light closest on the spectrum to visible light.”
Get in Touch
Email us with any questions or inquiries.
care@niraxx.com